loader
Please Wait
Applying Filters...

Renejix CDMO Partner for Small Molecule Oral Dosage Forms Renejix CDMO Partner for Small Molecule Oral Dosage Forms

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about CAS 1378391-45-7, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    CAS 1378391-45-7

    Manufacturers/Suppliers

    PharmaCompass

    Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.

    Athena Pharmaceutiques is a Partner of Choice for Drug Delivery & Life Cycle Management.

    2D Structure
    1. Also known as: 1378391-45-7, Tert-butyl (2s,4s)-2-[5-(2-{(2s,5s)-1-[n-(methoxycarbonyl)-l-valyl]-5-methylpyrrolidin-2-yl}-1,11-dihydroisochromeno[4 inverted exclamation marka,3 inverted exclamation marka:6,7]naphtho[1,2-d]imidazol-9-yl)-1h-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate, Tert-butyl (2s,4s)-2-[5-[6-[(2s,5s)-1-[(2s)-2-(methoxycarbonylamino)-3-methylbutanoyl]-5-methylpyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1h-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate, Schembl8752756, Amy4216, Mfcd29037364
    Molecular Formula
    C44H53N7O7
    Molecular Weight
    791.9  g/mol
    InChI Key
    DMFDIPBYFDWGGH-FABOOFKTSA-N
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    tert-butyl (2S,4S)-2-[5-[6-[(2S,5S)-1-[(2S)-2-(methoxycarbonylamino)-3-methylbutanoyl]-5-methylpyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1H-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate
    2.1.2 InChI
    InChI=1S/C44H53N7O7/c1-23(2)37(49-42(53)56-8)41(52)51-24(3)9-14-34(51)40-46-32-13-11-26-17-31-29-12-10-27(16-28(29)22-57-36(31)18-30(26)38(32)48-40)33-19-45-39(47-33)35-15-25(21-55-7)20-50(35)43(54)58-44(4,5)6/h10-13,16-19,23-25,34-35,37H,9,14-15,20-22H2,1-8H3,(H,45,47)(H,46,48)(H,49,53)/t24-,25-,34-,35-,37-/m0/s1
    2.1.3 InChI Key
    DMFDIPBYFDWGGH-FABOOFKTSA-N
    2.1.4 Canonical SMILES
    CC1CCC(N1C(=O)C(C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)C8CC(CN8C(=O)OC(C)(C)C)COC
    2.1.5 Isomeric SMILES
    C[C@H]1CC[C@H](N1C(=O)[C@H](C(C)C)NC(=O)OC)C2=NC3=C(N2)C=CC4=CC5=C(C=C43)OCC6=C5C=CC(=C6)C7=CN=C(N7)[C@@H]8C[C@@H](CN8C(=O)OC(C)(C)C)COC
    2.2 Synonyms
    2.2.1 Depositor-Supplied Synonyms

    1. 1378391-45-7

    2. Tert-butyl (2s,4s)-2-[5-(2-{(2s,5s)-1-[n-(methoxycarbonyl)-l-valyl]-5-methylpyrrolidin-2-yl}-1,11-dihydroisochromeno[4 Inverted Exclamation Marka,3 Inverted Exclamation Marka:6,7]naphtho[1,2-d]imidazol-9-yl)-1h-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate

    3. Tert-butyl (2s,4s)-2-[5-[6-[(2s,5s)-1-[(2s)-2-(methoxycarbonylamino)-3-methylbutanoyl]-5-methylpyrrolidin-2-yl]-21-oxa-5,7-diazapentacyclo[11.8.0.03,11.04,8.014,19]henicosa-1(13),2,4(8),5,9,11,14(19),15,17-nonaen-17-yl]-1h-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate

    4. Schembl8752756

    5. Amy4216

    6. Mfcd29037364

    7. Zinc203685546

    8. Ac-29305

    9. I11814

    10. (2s,4s)-2-[5-[1,11-dihydro-2-[(2s,5s)-1-[(2s)-2-[(methoxycarbonyl)amino]-3-methyl-1-oxobutyl]-5-methyl-2-pyrrolidinyl][2]benzopyrano[4',3':6,7]naphth[1,2-d]imidazol-9-yl]-1h-imidazol-2-yl]-4-(methoxymethyl)-1-pyrrolidinecarboxylic Acid 1,1-dimethylethyl Ester

    11. (2s,4s)-t-butyl 2-(5-(2-((2s,5s)-1-((s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-5-methylpyrrolidin-2-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1h-imidazol-2-yl)-4-(methoxymethyl)pyrrolidine-1-carboxylate

    12. (2s,4s)-tert-butyl2-(5-(2-((2s,5s)-1-((s)-2-((methoxycarbonyl)amino)-3-methylbutanoyl)-5-methylpyrrolidin-2-yl)-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1h-imidazol-2-yl)-4-(methoxymethyl)pyrrolidine-1-carboxylate

    13. Tert-butyl (2s,4s)-2-[5-(2-{(2s,5s)-1-[n-(methoxycarbonyl)-l-valyl]-5-methylpyrrolidin-2-yl}-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1h-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate

    14. Tert-butyl(2s,4s)-2-[5-(2-{(2s,5 S)-1-[n-(methoxycarbonyl)-l-valyl]-5-methylpyrrolidin-2-yl}-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1h-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate

    15. Tert-butyl(2s,4s)-2-[5-(2-{(2s,5s)-1-[n-(methoxycarbonyl)-l-valyl]-5-methylpyrrolidin-2-yl}-1,11-dihydroisochromeno[4',3':6,7]naphtho [1,2-d]imidazol-9-yl)-1h-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate

    16. Tert-butyl(2s,4s)-2-[5-(2-{(2s,5s)-1-[n-(methoxycarbonyl)-l-valyl]-5-methylpyrrolidin-2-yl}-1,11-dihydroisochromeno[4',3':6,7]naphtho[1,2-d]imidazol-9-yl)-1h-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate

    17. Tert-butyl(2s,4s)-2-[5-(2-{(2s,5s)-1-[n-(methoxycarbonyl)-l-valyl]-5-methylpyrrolidin-2-yl}-1,11-dihydroisochromeno[4\',3\':6,7]naphtho[1,2-d]imidazol-9-yl)-1h-imidazol-2-yl]-4-(methoxymethyl)pyrrolidine-1-carboxylate

    2.3 Create Date
    2012-11-30
    3 Chemical and Physical Properties
    Molecular Weight 791.9 g/mol
    Molecular Formula C44H53N7O7
    XLogP36.1
    Hydrogen Bond Donor Count3
    Hydrogen Bond Acceptor Count9
    Rotatable Bond Count11
    Exact Mass791.40064706 g/mol
    Monoisotopic Mass791.40064706 g/mol
    Topological Polar Surface Area164 Ų
    Heavy Atom Count58
    Formal Charge0
    Complexity1480
    Isotope Atom Count0
    Defined Atom Stereocenter Count5
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    Post Enquiry
    POST ENQUIRY